title: Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients.
abstract: Consensus-based recommendations have been developed by a Working Group of the World Health Organisation (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) on uniform reporting of tuberculosis (TB) treatment outcome data in countries in Europe. The main purpose of treatment monitoring is to find out how many of the potential infectious TB patients notified were declared cured at the end of treatment. Following the uniform case definitions as defined in 1996, emphasis is placed on cohort analysis of definite cases of pulmonary TB. The Working Group recommends using a minimal set of six mutually exclusive categories of treatment outcome: cure, treatment completed, failure, death, treatment interrupted, and transfer out. More detailed subsets may be chosen. Treatment outcome is expressed as a percentage of the total number of cases notified. Analysis should be separate for new and retreatment cases. Treatment outcome data have to be collected at the local level and passed on to regional and national authorities on an ongoing basis. Evaluation of treatment results becomes, preferably, an inbuilt component of national monitoring of programme performance. Because of the long duration of treatment, it is recommended that analysis is carried out in the first quarter of the calendar year that follows a full year after the last patient was enrolled. Feedback is essential. Treatment outcome results should become an inseparable part of the annual report on tuberculosis.
authors.affiliation: Royal Netherlands Tuberculosis Association (KNCV), The Hague.
authors.forename: J
authors.initials: J
authors.lastname: Veen
authors.forename: M
authors.initials: M
authors.lastname: Raviglione
authors.forename: H L
authors.initials: HL
authors.lastname: Rieder
authors.forename: G B
authors.initials: GB
authors.lastname: Migliori
authors.forename: P
authors.initials: P
authors.lastname: Graf
authors.forename: M
authors.initials: M
authors.lastname: Grzemska
authors.forename: R
authors.initials: R
authors.lastname: Zalesky
mesh_terms: D015331:Cohort Studies; D005060:Europe / Q000453:epidemiology; D006801:Humans; D017063:Outcome Assessment, Health Care; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology